Investigation of the gene polymorphism marker to predict the effect of lactoferrin on visceral fat reduction

Investigation of the gene polymorphism marker to predict the effect of lactoferrin on visceral fat reduction - Investigation of the gene polymorphism marker to predict the effect of lactoferrin on visceral fat reduction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042472

Enrollment

107

Registered

2020-11-16

Start date

2020-11-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No (healthy adults)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Persons to be analyzed of UMIN000031545. (2)Persons who have fully understood the purpose and contents of this test and has obtained written consent to participate in this test.

Exclusion criteria

Exclusion criteria: (1)Persons who have already participated in other clinical trials that affect lifestyle, such as diet, exercise, and sleep. (2)Persons who are judged as unsuitable for the study by the investigator for the other reason.

Design outcomes

Primary

Measure	Time frame
SNPs related to visceral fat, BMI reduction effect, etc. after 12 weeks of continuous intake of lactoferrin	—

Secondary

Measure	Time frame
Questionnaire about lifestyle	—

Countries

Japan

Contacts

Public ContactYoshiyuki Obayashi

LION Corporation Well-being Research Laboratories

yo-0324@lion.co.jp0465-49-4487

Outcome results